PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Suppliers list

Company Name:	Riedel-de Haen AG
Tel:	800 558-9160
Email:
Products Intro:	Purity:90% (HPLC), lyophilized powder

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Basic information

Product Name:	PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT
Synonyms:	PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT
CAS:
MF:	C55H101F3N20O14
MW:	1323.51
EINECS:
Product Categories:	Serine/Threonine Kinase Inhibitors;Cyclic Nucleotide Metabolism;Cyclic Nucleotides and AnalogsSerine/Threonine Kinase Biology;G Proteins and Cyclic Nucleotides;Protein Kinase A (PKA)
Mol File:	Mol File

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Chemical Properties

storage temp.	-20°C
form	lyophilized powder

Safety Information

Safety Statements	22-24/25
WGK Germany	3

MSDS Information

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Usage And Synthesis

Uses	Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt has been used in cell culture for pharmaceutical inhibition and activation studies.
General Description	Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt inhibits the protein kinase cAMP-activated catalytic subunit-α (PRKACA). The gene encoding it is localized on human chromosome 19p13.1.
Biochem/physiol Actions	Mutations in the gene encoding protein kinase cAMP-activated catalytic subunit-α (PRKACA) have been associated with Cushing′s syndrome.

PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Preparation Products And Raw materials

Tag:PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Related Product Information

Login